Qorvo Biotechnologies Awarded $24.4 Million National Institutes of Health Contract to Scale Point-of-Care COVID-19 Antigen Testing

On April 15, 2021

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5221

Related Post

TI expands space-grade product portfolio with radiation-hardened and radiation-tolerant plastic packages for missions from new space to deep space

Reach new depths with the Oceanic+ app and Apple Watch Ultra

Lockheed Martin to Deliver Web-Based Cyber Training to 17,000 U.S. Army Personnel